ZBH Zimmer Biomet Holdings Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 67
Relative Strength: Rel. Strength: 27
Relative Valuation: Rel. Valuation: 63
Relative Profitability: Rel. Profitability: 60

EPS in 2026 (TTM): $3.87

Last Report Period Date: Mar 31, 2026

Based on the company's latest reports for March 2026, the current 12-month EPS is $3.87. Zimmer Biomet Holdings's earnings per share in 2025 was reported at $3.56, marking a decline from $4.45 in 2024. In the quarterly report ending on Mar 31, 2026, ZBH's earnings per share amounted to $1.22.

ZBH earnings history

Historical annual and quarterly earnings per share (EPS) data for Zimmer Biomet Holdings
EPS (TTM)
$3.87
EPS Growth YoY (Quarterly)
32.6%
EPS (Quarterly)
$1.22
EPS Growth (Quarterly)
71.8%

Zimmer Biomet Holdings had an yealy earnings per share of $3.56, showing a decline of 20% from $4.45 recorded in 2024. The quarterly earnings per share for the period ending Mar 31, 2026, was $1.22, showing a 32.6% increase compared to the same quarter last year. The trailing twelve months EPS for ZBH is $3.87 as of March 2026. Zimmer Biomet Holdings's full-year EPS for 2024 was $4.45, a 9.4% decline compared to the previous year.

ZBH earnings chart

ZBH EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
32.6%
EPS growth YoY
-20%
EPS growth 3Y avg
47.9%
EPS growth 5Y avg
N/A

Zimmer Biomet Holdings has recorded a growth in earnings per share of 32.6% in the past 12 months (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 47.9% per year. When assessed over a ten-year period, ZBH's average EPS annual growth was 16.4%.

ZBH Earnings Waterfall

Breakdown of revenue, profit and net income for Zimmer Biomet Holdings

ZBH Earnings vs Peers

What are the earnings of ZBH compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
BSX Boston Scientific Corp 20.25 55.6% 63.3% N/A
ZBH Zimmer Biomet Holdings Inc 22.52 -20% 47.9% N/A
COO Cooper Companies Inc 31.04 -4.6% -1.2% 9.2%
SYK Stryker Corp 34.44 8% 10.9% 14.8%
EW Edwards Lifesciences Corp 46.26 -73.6% -9.2% 6.9%

All data is based on quarterly TTM periods, unless otherwise specified.